medline.ch Neurologie Multiple Sklerose

	Particulate Matter is Not Associated With Disease Worsening in Patients With Multiple Sclerosis: Retrospective Results From a Clinic-Based Cohort in the Northeastern United States. Brain Behav Lebiedz S, Healy B, Glanz B, Chitnis T, Madill E. PMID: 43006821 [PubMed - indexed for MEDLINE]
	Environmental and lifestyle factors in multiple sclerosis progression. Front Immunol Hedström AK. PMID: 43005840 [PubMed - indexed for MEDLINE]
	Music-4-MS to Improve Cognition and Psychosocial Well-Being in People Living With Multiple Sclerosis: A Randomized Controlled Feasibility Study. Int J MS Care Phillips CS, Becker H, Kesler SR, Freeman L, Kim J, Ha R, Dhillon S, Schroder A, Stuifbergen AM. PMID: 43005684 [PubMed]
	Blood glial fibrillary acidic protein in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol Masouri MM, Ebrahimi R, Ravari Nejad M, Hashempoor A, Bayati R, Noori S. PMID: 43004200 [PubMed - indexed for MEDLINE]
	Effects of adjunctive craniosacral therapy to conventional physiotherapy on postural responses and autonomic function in individuals with multiple sclerosis: a randomized controlled trial. Physiother Theory Pract Aslan H, Vural G, Aksoy S, Tekin RT. PMID: 43001615 [PubMed - as supplied by publisher]
	Revisiting Daclizumab for Multiple Sclerosis: A Systematic Evaluation of a Targeted Immunotherapy. Immunopharmacol Immunotoxicol Naghdi Y, Azhari Rad R, Keshavarzian M, Yousefi Z, Shams MH, Jafari R. PMID: 43000694 [PubMed - as supplied by publisher]
	Assessing the clinical- and cost-effectiveness of REFUEL-MS, a digital therapeutic for multiple sclerosis-related fatigue: study protocol for a randomised controlled trial. Trials Fawson S, Mortimer H, Abouzahr A, Proudfoot H, Ibrahimi E, Dodsworth N, Jackson T, Milne-Ives M, REFUEL-M. S. Patient Advisory Group, Sanders T, Finch T, Thomas S, Freeman J, van der Linden ML, Mercer T, Williams V, Barrett B, Norton S, Moss-Morris R. PMID: 43000399 [PubMed - indexed for MEDLINE]
	Microbiome-Derived Metabolites in Multiple Sclerosis: Mechanisms of Immune Regulation and Therapeutic Potential: A Literature Review. Cureus Amin MN. PMID: 42999727 [PubMed]
	A four-gene diagnostic panel for distinguishing primary progressive multiple sclerosis from HTLV-1-associated myelopathy/tropical spastic paraparesis. J Neuroimmunol Zarei Ghobadi M, Afsaneh E, Mozhgani SH. PMID: 42998510 [PubMed - as supplied by publisher]
	Comment on "Perceived value of physiotherapy and occupational therapy among people with multiple sclerosis: insights from a qualitative interview study". Mult Scler Relat Disord Purna Chandra Shekhar S, Katasani SBR, Kumar A. PMID: 42998451 [PubMed - as supplied by publisher]
	Depression, adverse childhood experiences, and cigarette smoking are associated with suicide attempts in people with multiple sclerosis: a cross-sectional exploratory study. J Neurol Freedman DE, Oh J, Feinstein A. PMID: 42998113 [PubMed - indexed for MEDLINE]
	Predictors of Long-Term Disability in Multiple Sclerosis: Up to 10 Years of Follow-up in a Real-World Cohort Study. Noro Psikiyatr Ars Uzunköprü C, Cengiz S, Beckmann Y. PMID: 42997598 [PubMed]
	The preclinical efficacy of Panax ginseng in multiple sclerosis: a systematic review and meta-analysis with a perspective on clinical translation. Nutr Neurosci Rezaee A, Mohammadi E, Rezaee M, Feyzabadi Z. PMID: 42995550 [PubMed - as supplied by publisher]
	Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes. Mult Scler Relat Disord Giovannoni G, Zaratin P, Samadzadeh S, Drulovic J, Thomas L, Stross R, Helme A, Reyes S, Ziemssen T, Hobart J. PMID: 42994312 [PubMed - as supplied by publisher]
	Objective assessment of gaze stabilization exercises in people with multiple sclerosis. Mult Scler Relat Disord Alghwiri AA, Obeidat FS, Li Z, Hovareshti P, Whitney SL. PMID: 42994311 [PubMed - as supplied by publisher]
	Catastrophic out-of-pocket (OOP) expenditure and perceived financial burden among people with multiple sclerosis in Egypt: A multicenter cross-sectional study. Mult Scler Relat Disord Hamdy E, Fouda B, Talaat F, Ramadan I, Said S, Steit AA. PMID: 42994310 [PubMed - as supplied by publisher]
	Is it time for anti-CD20 discontinuation in multiple sclerosis? Cumulative risk or cumulative uncertainty. Front Immunol Zanghì A, van der Walt A, D'Amico E. PMID: 42991313 [PubMed - indexed for MEDLINE]
	Longitudinal analysis of the effects of cladribine tablets on B and T cell memory recall responses to vaccine antigens in people with multiple sclerosis. Front Immunol Csurhes PA, McCombe PA, Greer JM. PMID: 42990905 [PubMed - indexed for MEDLINE]
	Healthcare professionals' perceptions and experiences of promoting physical activity in persons with multiple sclerosis: a systematic review of qualitative evidence. Disabil Rehabil Abonie US, Kurji-Smith N, Thomas S, Duddy M, Dawes H. PMID: 42989809 [PubMed - as supplied by publisher]
	Neurobehavioral phenotypes in multiple sclerosis: a data-driven classification using latent profile analysis. Neurol Sci Artemiadis A, Argyropoulou C, Liampas A, Bakirtzis C, Nikolaou G, Hadjigeorgiou G. PMID: 42989026 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 45273

Seite 1 von 2264

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung